Delphine Brugier

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Title Not Found

Title Not Found

Journal: The Canadian journal of hospital pharmacy

Published: March 22, 2025

Determinants of Late Supraventricular Arrhythmia After Patent Foramen Ovale Closure: Insights From a Prospective Cohort.

Determinants of Late Supraventricular Arrhythmia After Patent Foramen Ovale Closure: Insights From a Prospective Cohort.

Journal: The Canadian journal of cardiology

Published: February 10, 2025

A family-based strategy to identify and prevent premature cardiovascular disease: a feasibility pilot study.

A family-based strategy to identify and prevent premature cardiovascular disease: a feasibility pilot study.

Journal: European journal of preventive cardiology

Published: November 22, 2024

Flecainide to Prevent Atrial Arrhythmia After Patent Foramen Ovale Closure: AFLOAT Study, A Randomized Clinical Trial.

Flecainide to Prevent Atrial Arrhythmia After Patent Foramen Ovale Closure: AFLOAT Study, A Randomized Clinical Trial.

Journal: Circulation

Published: September 02, 2024

Defective biological activities of high-density lipoprotein identify patients at highest risk of recurrent cardiovascular event.

Defective biological activities of high-density lipoprotein identify patients at highest risk of recurrent cardiovascular event.

Journal: European journal of preventive cardiology

Published: August 23, 2024

Ten-year trends in characteristics, management and outcomes of patients admitted with cardiogenic shock in the ACTION-SHOCK cohort.

Ten-year trends in characteristics, management and outcomes of patients admitted with cardiogenic shock in the ACTION-SHOCK cohort.

Journal: Archives of cardiovascular diseases

Published: May 27, 2024

Flecainide to prevent atrial arrhythmia after patent foramen ovale closure, Rationale and design of the randomized AFLOAT study.

Flecainide to prevent atrial arrhythmia after patent foramen ovale closure, Rationale and design of the randomized AFLOAT study.

Journal: European heart journal. Cardiovascular pharmacotherapy

Published: September 08, 2023

Rationale and design of the ARAMIS trial: Anakinra versus placebo, a double blind randomized controlled trial for the treatment of acute myocarditis.

Rationale and design of the ARAMIS trial: Anakinra versus placebo, a double blind randomized controlled trial for the treatment of acute myocarditis.

Journal: Archives of cardiovascular diseases

Published: July 17, 2023

Prevention and treatment of premature ischaemic heart disease with European Society of Cardiology Guidelines.

Prevention and treatment of premature ischaemic heart disease with European Society of Cardiology Guidelines.

Journal: Heart (British Cardiac Society)

Published: July 26, 2022

Beta-blocker prescription and outcomes in uncomplicated acute myocardial infarction: Insight from the ePARIS registry.

Beta-blocker prescription and outcomes in uncomplicated acute myocardial infarction: Insight from the ePARIS registry.

Journal: Archives of cardiovascular diseases

Published: May 31, 2022

ESC/EAS guidelines for the detection, prevention, and treatment of individuals at risk of a first myocardial infarction: effect of 5 years of updates and the new SCORE2.

ESC/EAS guidelines for the detection, prevention, and treatment of individuals at risk of a first myocardial infarction: effect of 5 years of updates and the new SCORE2.

Journal: European heart journal. Cardiovascular pharmacotherapy

Published: February 03, 2022

Clinical Outcomes According to ECG Presentations in Infarct-Related Cardiogenic Shock in the Culprit Lesion Only PCI vs Multivessel PCI in Cardiogenic Shock Trial.

Clinical Outcomes According to ECG Presentations in Infarct-Related Cardiogenic Shock in the Culprit Lesion Only PCI vs Multivessel PCI in Cardiogenic Shock Trial.

Journal: Chest

Published: July 20, 2020

Showing 1-12 of 29

Last Updated: 09/26/2026